BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Clinical trial NCT06368960 · UNKNOWN
Trial details
- NCT number
- NCT06368960
- Sponsor
- InnoBM Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2024-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.